Healthcare Professionals
Learn more about the latest in technological innovations to ablate, necrotize or coagulate soft tissue in the brain.
Patients & Caregivers
Find out more about minimally invasive brain surgery technology for you or your loved one.
NEUROBLATE® SYSTEM
NeuroBlate® is the only minimally invasive, robotic, laser thermal therapy tool that uses MRI-guided surgical ablation technology designed specifically for use in the brain.
The Minimally Invasive Surgical Choice
NeuroBlate provides precise and maximal brain lesion ablation for patients without the invasiveness of an open neurosurgical procedure. The precise nature of the procedure helps lessen the likelihood of harm to nearby healthy tissue.1
NeuroBlate offers hope and healing to patients suffering from a wide range of neurological lesions, including brain tumors, radiation necrosis, and epileptic foci.
EXCLUSIVE TECHNOLOGIES
NeuroBlate delivers a comprehensive, full solution laser ablation system that includes software, disposables, and hardware.
TruTemp™ Technology
Provides confidence in the accuracy of the ablation zone and added safety assurance.
NeuroBlate Fusion™ Software
Allows neurosurgeons to plan, deliver, and monitor MRI-guided robotic laser thermal therapy.
NeuroBlate Optic™ Laser Probe
The first and only commercially available laser probe with fiber optic controlled cooling.
CLINICAL RESEARCH & TRIALS
Our commitment to clinical research is an essential and integral part of our mission and is demonstrated in our clinical trial work.
Active Clinical Trials
The Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate® System (LAANTERN) Prospective Registry is currently enrolling eligible patients.
LITT Evidence
The cumulative utilization of LITT over time has been steadily increasing for metastatic tumor, primary tumor, radiation necrosis, and epileptic foci.
FIND A PHYSICIAN
A Minimally Invasive Surgical Option
To locate physicians currently using the NeuroBlate System, please click here.
Please note, NeuroBlate is available in the U.S. and Canada only.
RECENT NEWS
Monteris Medical Announces Publication of Largest Series of NeuroBlate Laser Interstitial Thermal Therapy for Biopsy-Proven Radiation Necrosis
LITT allows for the prompt cessation of steroids and alleviates symptom burden in brain metastasis patients with radiation necrosis as supported by evidence from 90 patients treated with NeuroBlate laser ablation.
Monteris Medical Announces $73 Million in Combined Equity and Debt Financing
InnovaHealth Partners leads financing with Birchview Capital and Madryn Asset Management, LP, to accelerate commercial, clinical and product development priorities
Monteris Medical Announces First Patient Enrolled in REMASTer Clinical Study on NeuroBlate® System for Metastatic Brain Tumor Patients
Monteris Medical Announces First Patient Enrolled in REMASTer Clinical Study on NeuroBlate® System for Metastatic Brain Tumor Patients
The randomized controlled multicenter study is the first-of-its kind to investigate LITT benefits in radiographically recurrent brain metastasis patients
- Rennert RC, Khan U, Barktek J Jr et al. Laser Ablation of Abnormal Neurological Tissue Using Robotic Neuroblate System (LAANTERN): procedural safety and hospitalization. Neurosurgery. published online: May 11, 2019. (doi: 10.1093/neuros/nyz141)